Researchers from the Swiss National Science Foundation (SNSF) have developed a technique to identify which Ewing’s sarcoma cancer cells are most likely to trigger metastases and spread cancer within the body, the SNSF said in a statement on Wednesday.
Ewing’s sarcoma is a rare but very aggressive form of bone cancer that particularly affects children and young adults.
The scientists began by isolating the most dangerous cancer cells and growing them in a laboratory. They then genetically modified the tumour cells, introducing a gene that causes the dangerous cells to glow green if the cell is of the metastasising variety. The work has been published in the journal Science Advances.
More
More
Swiss-led research team uncovers key to treatment-resistant prostate cancer
This content was published on
A team led by the University of Bern has identified a key factor that causes some advanced prostate cancer to become resistant to hormonal therapy.
“Identifying the gene associated with the risk of metastases opens new avenues for research”, said Ivan Stamenkovic, co-author of the paper and professor of experimental pathology at the University Hospital Lausanne (CHUV).
It is hoped that identifying the most dangerous cancer cells will open the door for treatments that target specific cells, Stamenkovic said.
Employees in Switzerland increasingly stressed at work
This content was published on
The proportion of people in Switzerland who are stressed at work has increased by 5% over ten years, according to the Federal Statistical Office.
This content was published on
F/A-18 fighter jets will practice take offs and landings on the A1 motorway between Payerne and Avenches in canton Vaud on June 5.
Swisscom finalises financing for Vodafone Italia takeover
This content was published on
Telecoms group Swisscom has taken the next step in its takeover of Vodafone Italia and secured financing for the deal, the company said on Thursday.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
Swiss-led research team uncovers key to treatment-resistant prostate cancer
This content was published on
A team led by the University of Bern has identified a key factor that causes some advanced prostate cancer to become resistant to hormonal therapy.
This content was published on
Ahead of National Skin Cancer Day on Monday, the professor explains why the Swiss are so at risk and what the warning signs are for the illness. Panizzon, who is chairman of the dermatology department at Lausanne University Hospital, is one of 150 doctors around the country who will be conducting free consultations on National…
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.